Breaking News, Promotions & Moves

Regenxbio Updates Leadership, Names New CEO

New President and CEO, Curran Simpson, is a seasoned biopharmaceuticals leader with over 35 years of industry experience.

Author Image

By: Charlie Sternberg

Associate Editor

Regenxbio has promoted Curran Simpson, Chief Operating Officer, to President, Chief Executive Officer and a member of the Board of Directors, effective July 1, 2024.   Meanwhile, Co-Founder Kenneth T. Mills will step down as President and Chief Executive Officer following 15 years of leadership at the Company, and is taking on an expanded role on the Board as Chairman.   In connection with these changes, Board member Daniel Tassé has been appointed as Regenxbio’s Lead Independent Direc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters